|
KLHDC10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.20859988683719E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.32930025162648E-10 |
| Normal-vs-Stage2 |
1.361920E-03 |
| Normal-vs-Stage3 |
1.67859948163596E-10 |
| Normal-vs-Stage4 |
4.32149982465546E-10 |
| Stage1-vs-Stage2 |
1.594780E-01 |
| Stage1-vs-Stage3 |
1.911580E-01 |
| Stage1-vs-Stage4 |
4.128500E-02 |
| Stage2-vs-Stage3 |
3.656000E-02 |
| Stage2-vs-Stage4 |
1.800200E-02 |
| Stage3-vs-Stage4 |
4.724600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.73212571957993E-12 |
| Normal-vs-AfricanAmerican |
3.538900E-03 |
| Normal-vs-Asian |
8.9041000017609E-08 |
| Caucasian-vs-AfricanAmerican |
1.385760E-01 |
| Caucasian-vs-Asian |
8.249200E-01 |
| AfricanAmerican-vs-Asian |
1.235990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.94899709891206E-11 |
| Normal-vs-Female |
2.11500039704049E-10 |
| Male-vs-Female |
1.400950E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.29649996189119E-09 |
| Normal-vs-Age(41-60Yrs) |
7.00919999818694E-09 |
| Normal-vs-Age(61-80Yrs) |
9.3114005395023E-10 |
| Normal-vs-Age(81-100Yrs) |
7.425200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.515200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.874800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.193800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.932000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.894600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.256800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.284800E-03 |
| Classical-VS-Follicular |
8.044000E-01 |
| Classical-VS-Other |
9.727800E-02 |
| Classical-VS-Normal |
6.99770019707557E-10 |
| Tall-VS-Follicular |
3.394300E-02 |
| Tall-VS-Other |
4.967600E-01 |
| Tall-VS-Normal |
4.24939972099025E-10 |
| Follicular-VS-Other |
1.829560E-01 |
| Follicular-VS-Normal |
1.22670000002323E-06 |
| Other-VS-Normal |
3.756300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.58860005337192E-09 |
| Normal-vs-N1 |
6.17930040469616E-10 |
| N0-vs-N1 |
6.468100E-02 |
|
|
